
Castle Biosciences CSTL
$ 19.83
3.07%
Quarterly report 2026-Q1
added 05-06-2026
Castle Biosciences Operating Cycle 2011-2026 | CSTL
Annual Operating Cycle Castle Biosciences
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 97.4 | 97.9 | 99.7 | 88.5 | 107 | 158 | 165 | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 165 | 88.5 | 116 |
Quarterly Operating Cycle Castle Biosciences
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 97.4 | 96.9 | 97.5 | - | 93.8 | 95.7 | 102 | - | 98.6 | 97.6 | 93.7 | - | 92.9 | 89.6 | 96.7 | - | 116 | 119 | 122 | 67.3 | 158 | 186 | 138 | 75.8 | 157 | 181 | 200 | 96.5 | 357 | 169 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 357 | 67.3 | 127 |
Operating Cycle of other stocks in the Diagnostics research industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
170 | - | -6.23 % | $ 30.6 M | ||
|
Fulgent Genetics
FLGT
|
77.4 | $ 15.96 | 5.63 % | $ 483 M | ||
|
Burning Rock Biotech Limited
BNR
|
275 | $ 16.76 | 1.09 % | $ 177 M | ||
|
Agilent Technologies
A
|
161 | $ 115.62 | -2.55 % | $ 35.1 B | ||
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M | ||
|
Aspira Women's Health
AWH
|
1.2 K | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
489 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
134 | - | -13.05 % | $ 7.29 M | ||
|
CareDx, Inc
CDNA
|
51.5 | $ 21.82 | 1.77 % | $ 1.16 B | ||
|
Chembio Diagnostics
CEMI
|
164 | - | 0.22 % | $ 16.8 M | ||
|
Lantheus Holdings
LNTH
|
121 | $ 93.06 | 2.26 % | $ 6.28 B | ||
|
HTG Molecular Diagnostics
HTGM
|
216 | - | -20.0 % | $ 1.06 M | ||
|
Medpace Holdings
MEDP
|
50.4 | $ 424.0 | -1.1 % | $ 12.2 B | ||
|
Co-Diagnostics
CODX
|
1.79 K | $ 2.53 | 31.09 % | $ 3.37 M | ||
|
Myriad Genetics
MYGN
|
95.1 | $ 4.29 | 4.89 % | $ 397 M | ||
|
NeoGenomics
NEO
|
102 | $ 8.96 | -1.21 % | $ 1.15 B | ||
|
National Research Corporation
NRC
|
29.4 | $ 18.75 | 0.11 % | $ 420 M | ||
|
Global Cord Blood Corporation
CO
|
202 | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
11.8 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
185 | - | 0.12 % | $ 80.1 M | ||
|
Natera
NTRA
|
81.5 | $ 194.24 | -11.64 % | $ 19.1 B | ||
|
DermTech
DMTK
|
114 | - | -11.32 % | $ 2.94 M | ||
|
Charles River Laboratories International
CRL
|
65 | $ 177.62 | -2.23 % | $ 8.8 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
1.22 K | - | - | $ 10.7 B | ||
|
Enzo Biochem
ENZ
|
206 | - | -8.98 % | $ 14.8 K | ||
|
Koninklijke Philips N.V.
PHG
|
89 | $ 27.21 | 0.18 % | $ 25.8 B | ||
|
Exact Sciences Corporation
EXAS
|
91.7 | - | - | $ 19.8 B | ||
|
Personalis
PSNL
|
63.8 | $ 5.98 | -0.17 % | $ 534 M | ||
|
Guardant Health
GH
|
128 | $ 95.7 | 3.73 % | $ 12 B | ||
|
Senseonics Holdings
SENS
|
104 | $ 5.03 | -6.16 % | $ 210 M | ||
|
Soleno Therapeutics
SLNO
|
1.04 K | $ 52.95 | - | $ 2.69 B | ||
|
Heska Corporation
HSKA
|
177 | - | - | $ 1.31 B | ||
|
ICON Public Limited Company
ICLR
|
68.5 | $ 124.49 | -0.41 % | $ 10.3 B | ||
|
Illumina
ILMN
|
198 | $ 141.88 | 2.29 % | $ 22.6 B | ||
|
Interpace Biosciences
IDXG
|
96 | $ 1.95 | -2.5 % | $ 8.63 M | ||
|
QIAGEN N.V.
QGEN
|
172 | - | - | $ 10.6 B | ||
|
Trinity Biotech plc
TRIB
|
299 | $ 0.61 | 2.52 % | $ 219 M | ||
|
Twist Bioscience Corporation
TWST
|
96.1 | $ 56.85 | -2.89 % | $ 3.4 B | ||
|
Biomerica
BMRA
|
204 | $ 2.15 | -2.05 % | $ 4.94 M | ||
|
Thermo Fisher Scientific
TMO
|
70 | $ 465.0 | -1.99 % | $ 175 B | ||
|
Laboratory Corporation of America Holdings
LH
|
71.8 | $ 254.12 | -1.52 % | $ 21.1 B | ||
|
Motus GI Holdings
MOTS
|
3.45 K | - | -34.28 % | $ 263 K | ||
|
Waters Corporation
WAT
|
834 | $ 355.13 | 1.32 % | $ 21.1 B | ||
|
Neogen Corporation
NEOG
|
213 | $ 9.05 | -2.16 % | $ 1.96 B | ||
|
Quest Diagnostics Incorporated
DGX
|
54.2 | $ 187.39 | -1.82 % | $ 20.8 B |